OBI Pharma, Inc. (OBI), a clinical-stage global oncology company specialized in the development of novel cancer therapies ...

BAX launches five new injectible products in the United States, thus further strengthening its U.S Pharmaceuticals business ...

Desperate for cash to finance his brutal war, the Assad regime began the mass production of drugs. Fighters from Hezbollah, ...

For patients presenting with certain features at diagnosis or with active progressive disease, alkylating agents (e.g., chlorambucil, cyclophosphamide and bendamustine) and purine analogs ...

Long-term data from the pivotal phase 3 ELARA trial showed durable efficacy with tisagenlecleucel in high-risk follicular ...

Traditional wound care methods have limitations, highlighting the need for advanced bioactive dressings that enhance healing ...

Life-saving interventions may lead to ovarian dysfunction—casting a shadow of uncertainty over a survivor's ability to ...

Developments in chronic lymphocytic leukemia (CLL) this year included the first CAR T-cell therapy approval for the chronic ...

which consists either of surgery and radiotherapy or of surgery and radiotherapy plus the alkylating drug Temodar/Temodal (temozolomide) from Schering-Plough in Kenilworth, New Jersey. Subjects ...